5 shares I'd buy for income and growth in 2017

How will changing the interest rate environment impact ASX share market valuations.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The forthcoming of change of government in the United States and what it means for the global macro-economic environment has got investors reassessing what may be the next big share market winners.

The key change for investors since Donald Trump's U.S. election victory has been the sharp rise in the yield on U.S. government 10-year bonds. This yield is generally considered to be the benchmark risk-free rate of return available to investors over the medium term.

This is important to equity investors as shares must offer returns a fixed amount above the risk free rate in order to compensate investors for the inherent risks in share market investing. As the risk free rate has lifted the valuations of growth stocks have fallen as they are valued according to their longer-term (but unknown) earnings growth potential.

As an example this week the US FANG tech stocks like Facebook, Amazon and Netflix have been hammered as investors re-rate their present values relative to the certainty around their future cash flows and risk free returns available across other asset classes.

While in Australia the bond proxies like Transurban Group (ASX: TCL) and Sydney Airport Holdings Ltd (ASX: SYD) have tumbled as their income returns are no longer considered so valuable given the risks involved in owning businesses such as airports, which are vulnerable to a downturn due to an act of terror for example, among other risks.

So if neither growth or income stocks are any good going forward, where's an investor to look for the best returns in 2017?

The answer is to find those that offer good valuations, with modest growth potential and dividend returns.

Below I have five that I think fit the bill.

Lifehealthcare Group Ltd (ASX: LHC) is a junior healthcare provider that trades on just 10x analysts' estimates for earnings per share in financial year 2017, with a bumper 5.3% trailing dividend yield. Now that the regulatory concerns around this business appear to have lifted the shares look cheap at $2.36 given its decent outlook.

Event Hospitality and Entertainment Ltd (ASX: EVT) is an often overlooked business that offers a good mix of value and yield on around 16x estimated earnings with a 3.7% trailing yield. Moreover, as a hotelier (think QT Hotels) and leisure business it offers excellent leverage to the expected medium-term boom in inbound tourism.

JB Hi-Fi Limited (ASX: JBH) still trades on an undemanding 16x estimated forward earnings with the shares offering a fully franked trailing dividend yield in the region of 3.6%. The stock has been sold off recently as investors are nervous over news headlines around potential competition from the likes of Amazon. However, for now it looks set to retain a totally dominant position in bricks-and-mortar electronics retail. As such, shares look good value in my opinion.

Amcor Limited (ASX: AMC) is the global packaging business that offers a decent valuation and dividend yield in the region of 3.8%. It also offers exposure to a stronger US dollar thanks to its substantial operations in the region, although it is also now moving into China and Asia more broadly as its global empire expands. Selling for $14.12 the stock is likely to offer decent total returns for investors with a long-term time horizon.

Vocus Communications Limited (ASX: VOC) is the broadband, data centre, and fibre optic internet business that lost around 30% of its value last week after providing a market update. Its growing pains now look more than baked into the stock price and if you assume it can deliver 34 cents per share in earnings in FY17 it trades on just 12.5x  forward earnings with a yield likely to offer more than 4% fully franked. At $4.20 this stock looks undervalued to me.

Motley Fool contributor Tom Richardson owns shares of LifeHealthcare Group Limited and Vocus Communications Limited, Amazon and Facebook Inc. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »